The importance of adrenergic receptors (ARs) in the hippocampus has generally focused on ␤ARs; however, interest is growing in hippocampal ␣ARs given their purported neuroprotective role. We have previously reported ␣ 1 AR transcripts in a subpopulation of cornu ammonis 1 (CA1) interneurons. The goal of this study was to identify the specific ␣ 1 AR subtype (␣ 1A , ␣ 1B , ␣ 1D ) functionally expressed by these cells. Using cell-attached recordings to measure action potential frequency changes, concentration-response curves for the selective ␣ 1 AR agonist phenylephrine (PE) were generated in the presence of competitive subtype-selective ␣ 1 AR antagonists. Schild regression analysis was then used to estimate equilibrium dissociation constants (K b ) for each receptor antagonist in our system. The selective ␣ 1A AR antagonists, 5-methylurapidil and WB-4101 -765,314 (794 nM) and BMY7378 (316 nM) do not agree with affinity values for these antagonists at the ␣ 1B or ␣ 1D AR, respectively. Rather, these K b values more closely match equilibrium dissociation constants estimated for these compounds when used to identify ␣ 1A AR subtypes. Together, our results provide strong evidence to support functional expression of ␣ 1A ARs in a subpopulation of CA1 interneurons.
5]decane-7,9-dione dihydrochloride], produced significant rightward shifts in the concentration-response curve for PE only when used at nondistinguishing, micromolar concentrations. Calculated K b values for L-765,314 (794 nM) and BMY7378 (316 nM) do not agree with affinity values for these antagonists at the ␣ 1B or ␣ 1D AR, respectively. Rather, these K b values more closely match equilibrium dissociation constants estimated for these compounds when used to identify ␣ 1A AR subtypes. Together, our results provide strong evidence to support functional expression of ␣ 1A ARs in a subpopulation of CA1 interneurons.
Adrenergic receptors (ARs) comprise a family of G proteincoupled receptors that are physiologically activated by the catecholamines epinephrine and norepinephrine. Classified into ␣ 1 , ␣ 2 , and ␤AR types, these receptors traditionally signal through the heterotrimeric G proteins G q/11 , G i , and G s , respectively. The ␣ 1 AR in particular has become of increasing interest in neuroscience because ␣ 1 AR-mediated effects have been noted to regulate epileptiform activity (Weinshenker and Szot, 2002; Giorgi et al., 2004) , long-term synaptic depression (Kirkwood et al., 1999; Scheiderer et al., 2004) , as well as attention and cognition processes (Arnsten et al., 1999; Lapiz and Morilak, 2006) . Although these studies have identified ␣ 1 AR-mediated effects through careful use of selective ␣ 1 , ␣ 2 , or ␤AR pharmacological agents, further investigation into the specific ␣ 1 AR subtypes involved has not been pursued.
Three subtypes for the ␣ 1 AR are characterized: ␣ 1A , ␣ 1B , and ␣ 1D (for review, see Graham et al., 1996) . In situ hybridization studies in rat illustrate all three receptor subtypes are present in the central nervous system (CNS), with the ␣ 1A and ␣ 1B AR subtypes most prevalent (Pieribone et al., 1994; Day et al., 1997) . Recent studies utilizing enhanced green fluorescent protein-tagged ␣ 1A or ␣ 1B ARs have provided further insights into distribution of these receptors in the rodent CNS on both gross anatomical as well as cellular levels (Papay et al., 2004 (Papay et al., , 2006 . It is noteworthy that these latter studies offer increased resolution of ␣ 1 AR subtype expression in the hippocampus, a cortical structure implicated in many of the neuronal processes mentioned above. ␣ 1 AR activation in the hippocampus is associated with decreased excitability of the principal pyramidal neurons (Pang and Rose, 1987; Curet and de Montigny, 1988; Mynlieff and Dunwiddie, 1988) . This effect of ␣ 1 AR activation has been attributed to increased presynaptic GABA release from inhibitory interneurons (Bergles et al., 1996) , as well as postsynaptic NMDA receptor modulation (Scheiderer et al., 2004) .
We have previously reported ␣ 1A AR and ␣ 1B AR mRNA present in a subpopulation of interneurons in CA1, the most apical region of the hippocampus (Hillman et al., 2005b) . Cells containing these ␣ 1 AR transcripts predominate in stratum oriens and constitute a subpopulation of somatostatincontaining, GABAergic interneurons. Application of the selective ␣AR agonist 6-fluoronorepinephrine produces a concentration-dependent increased action potential frequency in these cells, which is blocked by the selective ␣ 1 AR antagonist prazosin but not the ␣ 2 AR selective antagonist rauwolscine (unpublished data). Although this response supports our molecular evidence of ␣ 1 AR transcription, it is unclear whether the ␣ 1A , the ␣ 1B ,or both ␣ 1 AR subtypes are responsible for this increased action potential frequency. Therefore, the goal of this study was to characterize the ␣ 1 AR subtype(s) functionally expressed by this subpopulation of CA1 interneurons. Clearly deducing which ␣ 1 AR subtype excites these interneurons will provide a greater level of specificity for future studies examining the influence of AR activation in the hippocampus.
Materials and Methods
Materials. D-(Ϫ)-2-Amino-5-phosphonopentanoic acid, atropine, 1,2-bis(2-aminophenoxy)ethane-N,N,NЈ,NЈ-tetraacetic acid, tetrapotassium salt, BMY7378, clonidine, 6,7-dinitroquinoxaline-2,3-dione, (Ϫ)-isoproterenol, L-765,314, 5-methylurapidil, MgATP, (R)-(Ϫ)-phenylephrine, NaGTP, and WB-4101 were obtained from SigmaAldrich (St. Louis, MO). Isoflurane was ordered from Abbott Diagnostics (Chicago, IL). All other chemical reagents were of biological grade and ordered through J.T. Baker, Inc. (Phillipsburg, NJ) or Fisher Scientific (Fairlawn, NJ).
Research Animals. Sprague-Dawley rat pups were obtained from Harlan (Indianapolis, IN) and housed with their mothers before weaning. After arrival, rats were allowed to acclimate for at least 2 days before their use. All protocols described have been approved by the Institutional Animal Care and Use Committee at the University of North Dakota, which is in accordance with the National Institutes of Health Guide for the Care and Use of Laboratory Animals.
Slice Preparation. Sprague-Dawley rats weighing 25 to 55 g were deeply anesthetized with isoflurane and decapitated. Brains were rapidly removed and placed in chilled solution containing 110 mM choline chloride, 25 mM NaHCO 3 , 25 mM D-glucose, 11.6 mM sodium ascorbate, 7 mM MgSO 4 , 3.1 mM sodium pyruvate, 2.5 mM KCl, 1.25 mM NaPO 4 , and 0.5 mM CaCl 2 . Using an HM650V vibratome (Microm, Walldorf, Germany), 400-m coronal sections were cut and transferred to a holding solution of 130 mM NaCl, 3.5 mM KCl, 5 mM MgCl 2 , 0.5 mM CaCl 2 , 1.25 mM NaH 2 PO 4 , 24 mM NaHCO 3 , and 10 mM D-glucose. Slices were incubated for 30 min at 37°C and then moved to room temperature. During experimentation, individual slices were continually bathed in artificial cerebral spinal fluid (aCSF) consisting of 119 mM NaCl, 5 mM KCl, 1.3 mM MgSO 4 , 2.5 mM CaCl 2 , 1 mM NaH 2 PO 4 , 26.2 mM NaHCO 3 , and 11 mM D-glucose. To pharmacologically isolate the cell of interest from primary excitatory inputs, 1 M atropine, 10 M 6,7-dinitroquinoxaline-2,3-dione, and 50 M D-(Ϫ)-2-amino-5-phosphonopentanoic acid were also included in the aCSF. All solutions were continually aerated with 95% O 2 and 5% CO 2 .
Cell-Attached Recording. Micropipettes were prepared from borosilicate glass using a vertical PP-830 puller (Narishige, Tokyo, Japan). Pipettes were filled with an internal solution of 135 mM KCH 3 SO 4 , 8 mM NaCl, 10 mM HEPES, 2 mM MgATP, 0.3 mM NaGTP, and 0.1 mM 1,2-bis(2-aminophenoxy)ethane-N,N,NЈ,NЈ-tetraacetic acid, tetrapotassium salt. Using a BX51WI upright microscope (Olympus, Melville, NY), the hippocampus was visualized under infrared-differential interference contrast optics. A candidate CA1 interneuron from stratum oriens or stratum radiatum was identified and centered in the visual field. With the micropipette, a gigaohm seal was formed on the soma of the candidate interneuron, enabling an isolated recording while maintaining integrity of the cell membrane. A baseline action potential frequency was recorded for 25 min, allowing time for equilibration of an AR antagonist if warranted by the experiment. Increasing concentrations of a specified AR agonist were then added to the perfusion line in 8-min increments. Changes in action potential frequency were visualized in real time and recorded for subsequent analysis. To avoid issues of receptor desensitization and depolarization block, only one hippocampal slice was used per experimental paradigm. After a single concentrationresponse curve was generated from an interneuron, generating an n ϭ 1, the hippocampal slice was discarded, and a new slice was equilibrated in aCSF. Action potentials were detected using an Axoclamp 700B (Molecular Devices Corporation, Sunnyvale, CA), digitized with a Digidata 1322A analog-to-digital converter (Molecular Devices), and recorded using Axoscope 9.2 software (Molecular Devices). Postexperimental analysis was completed using Mini Analysis 5.0 (Synaptosoft, Decatur, GA) and Prism 4.03 (GraphPad Software Inc., San Diego, CA).
Statistical Analysis. All values are reported as the mean Ϯ S.E., n Ն 3 as indicated. Action potential frequencies recorded during the course of each functional experiment were used to plot a concentration-response curve expressed as a percentage of the maximal AR agonist response. A fitted iterative nonlinear regression curve was used to determine the effective AR agonist concentrations that caused EC 50 . The fitted iterative nonlinear regression curve that best represented the data were determined using a partial
where SS is sum of the squares, and df is degrees of freedom (p Ͻ 0.05). Significance between experimental groups was tested using a one-way analysis of variance with a post hoc Bonferroni test (Fig. 1) or an unpaired two-tailed Student's t test (p Ͻ 0.05). Equilibrium dissociation constants (K b ) for subtype-selective ␣ 1 AR antagonists were estimated as described previously (Hillman et al., 2005a) , using the method of Arunlakshana and Schild (1959) . Schild regression slopes are expressed as the mean Ϯ S.E. and were considered different from unity if the 95% confidence interval did not include a value of 1 (Kenakin, 1997) .
Results
␣ 1 AR Activation Produces a Concentration-Dependent Increase in Action Potential Frequency. To understand the relationship between previously characterized mRNA expression patterns and functional receptor expression, a cell-attached configuration was used to record action potential frequencies from visually identified CA1 interneu-CA1 Interneurons Express ␣ 1A Adrenergic Receptors rons. Interneurons that provided a stable baseline recording for at least 25 min were challenged with increasing concentrations of the selective ␣ 1 AR agonist phenylephrine (PE), the selective ␣ 2 AR agonist clonidine, or the selective ␤AR agonist isoproterenol. As shown in Fig. 1 , PE produced a concentration-dependent increase in action potential frequencies, reaching a maximal effect at 100 M. Contrary to the effect of PE, no change in action potential frequency was observed with increasing concentrations of clonidine or isoproterenol. Results from these initial experiments suggest a specific CA1 interneuron population is excited in response to ␣ 1 AR activation.
␣ 1A AR Antagonism Alters the CA1 Interneuron Response to PE. To determine which ␣ 1 AR subtype(s) are functionally expressed by CA1 interneurons, we examined the effect of subtype-selective ␣ 1A AR antagonists on the PEmediated increased action potential frequency. Hippocampal slices were allowed to equilibrate with fixed concentrations of competitive receptor antagonist for at least 25 min before the onset of experimentation. Pretreatment of slices with 20, 50, or 100 nM of the selective ␣ 1A AR antagonist 5-methylurapidil produced consecutive parallel rightward shifts in the PE concentration-response curve ( Fig. 2A) . PE dose ratios in the presence and absence of each 5-methylurapidil concentration were calculated from individual experiments and used to generate a Schild regression line (Fig. 2B ). This analysis estimated an equilibrium dissociation constant (K b ) for 5-methylurapidil of 10.0 Ϯ 5.0 nM, a value that best correlates to previously published affinities of this competitive AR antagonist at the ␣ 1A AR (Table 1) .
A second subtype-selective ␣ 1A AR antagonist, WB-4101, was used to further support the idea that the CA1 interneuron response to PE is mediated by ␣ 1A AR activation. Fixed WB-4101 concentrations of 10, 30, and 50 nM produced consecutive parallel rightward shifts in the PE concentrationresponse curve (Fig. 2C) . EC 50 values obtained from these experiments were used to calculate dose ratios required for Schild regression analysis (Fig. 2D) , which provided an estimated K b of 5.0 Ϯ 1.2 nM for WB-4101 in our system. Although WB-4101 is not as selective for the ␣ 1A AR subtype as 5-methylurapidil (Table 1) , the high-affinity experimental value calculated for WB-4101 to inhibit PE-mediated increased action potential frequencies in CA1 interneurons suggests involvement of the ␣ 1A AR and/or ␣ 1D AR subtype. Although ␣ 1A AR expression is supported by our experimentation using 5-methyurapidil, as well as our previously published mRNA profiling, one cannot discount the possibility that ␣ 1D ARs are also expressed by these cells. As evident in Table 1 , the estimated K b of WB-4101 in our system could correlate to previously published affinity values for this competitive AR antagonist at the ␣ 1D AR. Therefore, we next used a selective ␣ 1D AR competitive antagonist to test any contribution that this AR subtype may have to the PE-mediated increase in action potential frequencies observed for CA1 interneurons.
Subtype-Selective ␣ 1D or ␣ 1B AR Competitive Antagonists Alter CA1 Interneuron Responses to PE Only at Nonspecific Concentrations. The selectivity for the competitive receptor antagonist BMY7378 is over 100-fold for the ␣ 1D versus the ␣ 1A or ␣ 1B AR subtypes, as determined using both functional and radioligand binding techniques (Goetz et al., 1995; Piascik et al., 1995) . Therefore, to establish whether the ␣ 1D AR subtype is contributing to agonist-mediated changes in action potential frequency observed for CA1 interneurons, this selective ␣ 1D AR antagonist was used in conjunction with increasing concentrations of PE. BMY7378 did not significantly affect the interneuron response to PE when this competitive antagonist was used at selective concentrations that block the ␣ 1D AR subtype (data not shown). The lowest concentration of BMY7378 needed to provide a statistically significant shift of the PE concentration-response curve was 0.5 M (Fig. 3A) . PE EC 50 dose ratios calculated from each individual experiment containing a fixed concentration of BMY7378 were subsequently used for Schild regression analysis, which estimated a K b value of 316 Ϯ 120 nM for this selective ␣ 1D AR antagonist in our system (Fig. 3B) . Compared with previous reports, this K b value does not correlate to calculated affinities of BMY7378 for the ␣ 1D AR, thus eliminating the possibility that activation of this ␣ 1 AR subtype contributes to the PE-mediated increase in CA1 interneuron action potential frequency (Table 1) .
Because BMY7378 does not further discriminate between the ␣ 1A or ␣ 1B AR, we used another AR competitive antagonist, L-765,314 , that has demonstrated high affinity for the ␣ 1B AR subtype in both functional and radioligand binding analysis (Patane et al., 1998; Jä hnichen et al., 2004) . L-765,314 did not produce significant shifts in the PE concentration-response curve when used at nanomolar concentrations that are selective for competitively interacting with the ␣ 1B AR (data not shown). Significant shifts in the PE concentration-response curve were observed only when L-765,314 was used at nonselective, micromolar concentrations (Fig. 4A) . Schild regression plots of the PE EC 50 dose Fig. 1 . Differing effects of ␣ 1 , ␣ 2 , and ␤AR activation on CA1 interneuron activity. A, hippocampal CA1 interneurons were challenged with increasing concentrations of either the selective ␣ 1 AR agonist PE (Ⅺ), the selective ␣ 2 AR agonist clonidine (f), or the selective ␤AR agonist isoproterenol ( ). Only the ␣ 1 AR agonist PE produced a significant ‫,ء(‬ p Ͻ 0.05; ‫,ءءء‬ p Ͻ 0.001) concentration-dependent increase of interneuron action potential frequency. Action potentials are normalized for each AR agonist and shown as percentage of baseline, n ϭ 3. B, representative trace of action potentials recorded from a CA1 stratum oriens interneuron, demonstrating increased action potential frequency in response to ␣ 1 AR activation. ratio data points versus receptor antagonist concentration estimated a 794 Ϯ 60 nM K b value for L-765,314 (Fig. 4B) . This experimental equilibrium dissociation constant calculated for L-765,314 is approximately 150 times greater than its published binding affinity at the ␣ 1B AR, which strongly suggests that this ␣ 1 AR subtype is not responsible for the PE-initiated effect observed in our system (Table 1) . Furthermore, this calculated K b is over 15-fold greater than the affinity of L-765,314 documented for the ␣ 1D AR, again substantiating our results using BMY7378, which showed no involvement of the ␣ 1D AR subtype in mediating this same response. Taken together, experimental K b values obtained in our studies for both receptor antagonists L-765,314 and BMY7378 most closely associate to affinity values published for the ␣ 1A AR. Therefore, the experimental K b profile of subtype-selective ␣ 1 AR antagonists used in this study implicates functional expression of the ␣ 1A AR subtype in PEresponsive CA1 interneurons.
Discussion
The goal of this study was to functionally characterize ␣ 1 AR subtypes expressed by CA1 interneurons in rat hippocampus. Using single-cell reverse transcription-polymerase chain reaction, we have shown previously ␣ 1 AR transcripts are present in a subpopulation of GABAergic Combined binding affinity values (mean Ϯ S.E.) of subtype-selective AR antagonists for cloned nonhuman ␣ 1 AR subtypes (rat ␣ 1A , ␣ 1B , and ␣ 1D ; hamster ␣ 1B ) (adapted from Lomasney et al., 1991; Laz et al., 1994; Perez et al., 1994; Goetz et al., 1995; Piascik et al., 1995; Saussy et al., 1996; Patane et al., 1998) . interneurons in this region of the hippocampus (Hillman et al., 2005b) . Preliminary experiments in our laboratory revealed a concentration-dependent increase of interneuron action potential frequencies following application of the selective ␣AR agonist 6-fluoronorepinephrine or the selective ␣ 1 AR agonist PE. Although this functional response substantiated our molecular studies, it was not clear which specific ␣ 1 AR subtype(s) mediated this effect. Using four different subtype-selective ␣ 1 AR antagonists to competitively inhibit the PE-mediated increased action potential frequency, we have demonstrated here that a subpopulation of CA1 interneurons functionally express the ␣ 1A AR. This report represents the first description for the functional distribution of a specific ␣ 1 AR subtype in a defined region of the hippocampus. As summarized in Table 1 , the calculated K b profile of all four subtype-selective ␣ 1 AR antagonists used in our analysis best correlate with previously published K i values of these same compounds for the ␣ 1A AR. The competitive receptor antagonists 5-methylurapidil and WB-4101, which are most selective for the ␣ 1A AR subtype, demonstrated a high affinity to inhibit PE-initiated action potentials in CA1 interneurons, suggesting ␣ 1A AR subtypes are probably expressed in these cells. Although our estimated K b values for 5-methylurapidil and WB-4101 were slightly higher than earlier reported K i values at the ␣ 1A AR, this discrepancy is probably attributable to our use of hippocampal slice preparations. For example, previous studies using 5-methylurapidil were performed on transfected COS-1 (Perez et al., 1994) , COS-7 (Laz et al., 1994) , or fibroblast cultures (Saussy et al., 1996) , allowing an isolated environment in which to study ␣ 1 AR expression. Although these earlier studies provide important information regarding ␣ 1 AR subtype characterization, the goal of our investigation was to examine ␣ 1 AR subtype expression in a more physiological context within a specific region of the CNS. The use of hippocampal slices, although enabling us to identify ␣ 1 AR expression patterns of individual interneurons within the brain, also introduces intact neuronal networks not present in transfected cell systems. Although much care is taken to pharmacologically isolate the interneuron of interest from primary inputs, residual network activity probably accounts for minor discrepancies between our experimental K b and previously published K i values for 5-methylurapidil and WB-4101. Regardless, the high-affinity values calculated for 5-methylurapidil and WB-4101 to inhibit PE-initiated action potentials in our system suggest ␣ 1A ARs are probably expressed by this subpopulation of CA1 interneurons. However, we could not completely rule out the possibility that our results obtained using WB-4101 suggest expression of the ␣ 1A AR and/or the ␣ 1D AR subtypes.
To delineate functional expression between these two ␣ 1 AR subtypes, BMY7378, a compound that has over a 100-fold selectivity for the ␣ 1D versus the ␣ 1A or ␣ 1B AR, was employed (Goetz et al., 1995) . The calculated low affinity of BMY7378 Fig. 3 . Effect of the selective ␣ 1D AR antagonist BMY7378. A, pretreatment with 0.5 M (F), 5 M (E), or 50 M (OE) of BMY7378 produced significant (p Ͻ 0.05) parallel rightward shifts in the PE concentration-response curve [EC 50 , 17 Ϯ 1.6, 86 Ϯ 11, and 426 Ϯ 32 M versus 7.7 Ϯ 0.15 M control (ϫ), n ϭ 3]. B, dose ratios calculated from each individual experiment were used for Schild regression analysis, which estimated an x-intercept value of Ϫ6.5 Ϯ 0.2 with a slope of 0.9 Ϯ 0.1. in our system (Ͼ300 nM) suggests that ␣ 1D ARs are not functionally responsible for the PE-mediated increase in action potential frequency seen in CA1 interneurons, substantiating our conclusions for ␣ 1A AR expression based on affinity values of 5-methylurapidil and WB-4101. This calculated low-affinity value for BMY7378 is supported by previous in situ studies that report almost no hybridization for the ␣ 1D AR subtype in rat hippocampus (Day et al., 1997) and substantiates our earlier findings that ␣ 1D AR transcripts are absent in CA1 interneurons (Hillman et al., 2005b) .
Although the low K b value estimated for BMY7378 in our system suggests ␣ 1D ARs are not involved in the PE-mediated increase in action potential frequency, it does not further distinguish between functional expression of the ␣ 1A or ␣ 1B AR subtype (Table 1) ; therefore, the selective ␣ 1B AR competitive antagonist L-765,314 was used for further analysis. The calculated low affinity (Ͼ700 nM) of L-765,314 in our system strongly implies that the ␣ 1B AR subtype does not contribute to the observed PE-mediated increased action potential frequency. L-765,314 produced significant shifts of the PE concentration-response curve only when used at very high concentrations, which relates to receptor antagonism of the ␣ 1A or ␣ 1D AR subtype. However, the published K i value for L-765,314 at the ␣ 1D AR is 50 nM, which is 15-fold lower than the functional K b calculated in our study for this same receptor antagonist. Consequently, this calculated equilibrium dissociation constant of L-765,314 is most indicative for the expression of an ␣ 1A AR subtype, further substantiating our results using 5-methylurapidil and WB-4101. Moreover, the low-affinity value calculated for BMY7378 rules out any possible contribution of an ␣ 1D AR subtype mediating this PE-initiated response, significantly supporting our conclusions that only ␣ 1A AR subtypes are functionally coupled to increasing action potential frequencies on these interneurons.
A lack of ␣ 1B AR involvement was surprising, given the fact that transcripts for both the ␣ 1A and ␣ 1B AR were found in cytoplasmic samples taken from CA1 interneurons (Hillman et al., 2005b) . Previous in situ studies also demonstrate ␣ 1B AR mRNA in CA1 (Pieribone et al., 1994; Day et al., 1997) , although these studies often report ␣ 1A AR expression in the hippocampus at a greater density. The predominance of ␣ 1A AR subtype expression in the hippocampus is supported by binding studies (Wilson and Minneman, 1989 ) and more specifically in CA1 hippocampus by enhanced green fluorescent protein-tagged ␣ 1 AR localization experiments (Papay et al., 2006) . One could speculate that both ␣ 1A and ␣ 1B AR subtypes are transcribed in CA1, with only the ␣ 1A AR translating into a functional protein. Considering that neurotransmitter receptor dysregulation and neuronal cell death has been observed in transgenic animals overexpressing the ␣ 1B AR subtype, this lack of functional ␣ 1B AR expression may be a beneficial adaptation (Yun et al., 2003) .
Alternatively, the ␣ 1B AR may be a functionally expressed membrane protein that simply is not linked to the receptor agonist-mediated increases in action potential frequency monitored for this study. In our experiments, we elected to use single-cell, cell-attached recordings to enable generation of complete concentration-response curves from individual interneurons within the CA1 hippocampus. Although the approach allowed us to perform pharmacological analysis on single cells in an in vitro physiological context, this technique is limited in that it detects only the all-or-none action potential. With regard to functional ␣ 1B AR or ␣ 1D AR expression in CA1, monitoring subthreshold changes in membrane potential by performing whole-cell interneuron recordings may provide better insight into possible functional contributions of these other ␣ 1 AR subtypes. However, due to dialysis of cell contents over time, this more sensitive technique of wholecell recording would not allow for generation of entire concentration-response curves, thus limiting complete characterization using pharmacological analysis.
It should be noted that not all CA1 interneurons examined responded to selective ␣ 1 AR agonism. Approximately 75% of interneurons in stratum oriens and 25% in stratum radiatum generated concentration-dependent increases in action potential frequencies following PE application. The remaining interneurons tested showed no change in baseline action potential frequency following applications of up to 100 M PE. This is consistent with our previous molecular findings that ␣ 1 AR transcripts are present only in a subset of somatostatin-positive interneurons (Hillman et al., 2005b) , a subpopulation of interneurons that predominate in stratum oriens of CA1 (Freund and Buzsá ki, 1996) . Interestingly, voltage-activated K ϩ conductance was recently shown to modulate cell excitability in this same subset of CA1 interneurons (Lawrence et al., 2006) , perhaps suggesting, at least in part, a possible mechanism behind the PE-mediated interneuron depolarization we observed in this study. Presently, it is important to consider our observed ␣ 1A AR-mediated effects only within the confines of a specific CA1 cell population, at least until further characterizations can be made throughout the entire hippocampal network.
On a wider scope, current laboratory investigations suggest that ␣ 1A AR activation on CA1 interneurons decreases activity of neighboring principal pyramidal cells via both neurotransmitter and neuropeptide release. This observation of a selective ␣ 1A AR-mediated effect represents a potentially novel therapeutic target for antiepileptic drug exploration. The hippocampus is a focal point for the majority of temporal lobe epilepsies, and CA1 neurons are particularly susceptible to cell death following instances of epileptiform activity. ␣ 1 AR activation has been shown to decrease spontaneous excitatory activity in cultured hippocampal neurons (Croce et al., 2003) , as well as increase CA1 inhibitory tone in hippocampal slices (Bergles et al., 1996) . In a recent case study, administration of an ␣ 1 AR antagonist in a patient with temporal lobe epilepsy was recently shown to be highly proconvulsant (Ivañ ez and Ojeda, 2006) . Therefore, it can be speculated that selective activation of ␣ 1A AR subtypes in the CA1 hippocampus may represent a novel way to increase inhibitory tone, which would serve to decrease epileptiform activity and promote neuronal survival in this region of the CNS.
In summary, by functionally determining affinity values for a panel of competitive subtype-selective ␣ 1 AR antagonists, we demonstrate for the first time at a single-cell level that ␣ 1A AR activation can mediate an increased action potential frequency in CA1 interneurons. Although ␣ 1A AR-mediated responses cannot be assumed to be present throughout the entire hippocampus, the identification of a specific functional ␣ 1 AR subtype in CA1 will help focus future adrenergic studies in this region. 
